OptimizeRx Corp CEO William Febbo's 2021 pay jumps 1,055% to $15M
OptimizeRx Corp reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
OptimizeRx Corp reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, four executives at OptimizeRx Corp received on average a compensation package of $5.4M, a 325% increase compared to previous year.
Average pay of disclosed executives at OptimizeRx Corp
William J. Febbo, Chief Executive Officer, received $15M in total, which increased by 1,055% compared to 2020. 93% of Febbo's compensation, or $14M, was in stock awards. Febbo also received $610K in non-equity incentive plan, $410K in salary, as well as $16K in other compensation.
Edward Stelmakh, Chief Financial Officer, received a compensation package of $3.2M. 63% of the compensation package, or $2M, was in stock awards.
Marion K. Odence-Ford, General Counsel, earned $2.5M in 2021.
Stephen L. Silvestro, Chief Commercial Officer, received $1.2M in 2021.
Related executives
You may also like
Source: SEC filing on April 25, 2022.